Results 351 to 360 of about 2,206,632 (403)
A global survey of potential acceptance of a COVID-19 vaccine
Nature Medicine, 2020 Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine.
Jeffrey V Lazarus +2 more
exaly +2 more sources
Emerging concepts in the science of vaccine adjuvants
Nature Reviews Drug Discovery, 2021 Adjuvants are vaccine components that enhance the magnitude, breadth and durability of the immune response. Following its introduction in the 1920s, alum remained the only adjuvant licensed for human use for the next 70 years.
Bali Pulendran, Prabhu S Arunachalam
exaly +2 more sources
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Nature, 2020 A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to control the coronavirus disease 2019 (COVID-19) global pandemic.
Kizzmekia S Corbett +2 more
exaly +2 more sources
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
Nature Medicine, 2021 Widespread acceptance of COVID-19 vaccines is crucial for achieving sufficient immunization coverage to end the global pandemic, yet few studies have investigated COVID-19 vaccination attitudes in lower-income countries, where large-scale vaccination is ...
Julio S Solís Arce +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
New England Journal of Medicine, 2023BACKGROUND Respiratory syncytial virus (RSV) infection causes considerable illness in older adults. The efficacy and safety of an investigational bivalent RSV prefusion F protein-based (RSVpreF) vaccine in this population are unknown.
E. Walsh +30 more
semanticscholar +1 more source